Una revisión sistemática de la eficacia de adalimumab, etanercept e infliximab para el tratamiento de la artritis reumatoide en adultos y una evaluación económica de su coste-efectividad

Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2008
Cargando información sobre las referencias

CRD SUMMARY:

This review concluded that adalimumab, etanercept and infliximab are effective treatments compared with placebo for patients with rheumatoid arthritis who are not well-controlled by disease-modifying antirheumatic drugs. Combination with methotrexate seems more effective in early rheumatoid arthritis. An increased risk of infection may occur when adalimumab or infliximab are combined with methotrexate. Despite some limitations, these conclusions are likely to be reliable.
Epistemonikos ID: 31abce11ba23d8244e566e5da723fac66c8c58a4
First added on: Jun 08, 2012